Global Healthcare Group

Houlihan Lokey’s Healthcare Group is pleased to share these recent accomplishments highlighting the activity and breadth of its global team as it gathers momentum in 2023.

Houlihan Lokey’s Healthcare Group has built a reputation for providing a collaborative, team-based approach that puts its clients’ interests first and delivers superior outcomes in both M&A advisory and capital-raising assignments. Our team consists of 85 dedicated bankers across the globe, making it one of the largest healthcare teams in the investment banking space. In 2022, Refinitiv ranked our team as the No. 1 M&A advisor for transactions under $1 billion* with 37 healthcare M&A deals.

For more information on the team’s services or to discuss how the firm can help advance your vision, please contact your Houlihan Lokey representative or one of the individuals listed at the end of this message.

Click on transactions from the past seven months for more details.

*Excludes accounting firms and brokers.

About Houlihan Lokey

Houlihan Lokey, Inc. (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. Houlihan Lokey serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. The firm is the No. 1 investment bank for all global M&A transactions, the No. 1 M&A advisor for the past nine consecutive years in the U.S., the No. 1 global restructuring advisor for the past ten consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by LSEG (formerly Refinitiv).